Torthaí cuardaigh - Keith M. Kerr
- 1 - 20 toradh as 109 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Pulmonary adenocarcinomas: classification and reporting de réir Keith M. Kerr
Foilsithe / Cruthaithe 2009Artigo -
2
Pulmonary preinvasive neoplasia de réir Keith M. Kerr
Foilsithe / Cruthaithe 2001Revisão -
3
Non–Small Cell Lung Cancer, PD-L1, and the Pathologist de réir Keith M. Kerr, M. Nicolson
Foilsithe / Cruthaithe 2016Revisão -
4
The association between atypical adenomatous hyperplasia and primary lung cancer de réir Andrea D. Chapman, Keith M. Kerr
Foilsithe / Cruthaithe 2000Artigo -
5
Programmed Death Ligand-1 Immunohistochemistry: Friend or Foe? de réir Keith M. Kerr, Fred R. Hirsch
Foilsithe / Cruthaithe 2016Artigo -
6
Precision medicine in NSCLC and pathology: how does ALK fit in the pathway? de réir Keith M. Kerr, Fernando López‐Ríos
Foilsithe / Cruthaithe 2016Revisão -
7
PD-1 blockade in advanced NSCLC: A focus on pembrolizumab de réir Solange Peters, Keith M. Kerr, Rolf A. Stahel
Foilsithe / Cruthaithe 2017Revisão -
8
Thyroid transcription factor 1 in pulmonary adenocarcinoma de réir G Stenhouse, Nicky Fyfe, George King, A Chapman, Keith M. Kerr
Foilsithe / Cruthaithe 2004Artigo -
9
Cytology for PD-L1 testing: A systematic review de réir John R. Gosney, Anne-Marie Boothman, M. Ratcliffe, Keith M. Kerr
Foilsithe / Cruthaithe 2020Revisão -
10
Gene Expression Profiling in Non-Small Cell Lung Cancer de réir Russell Petty, M. Nicolson, Keith M. Kerr, Elaina Collie–Duguid, Graeme I. Murray
Foilsithe / Cruthaithe 2004Revisão -
11
Familial Syndromes Involving Meningiomas Provide Mechanistic Insight Into Sporadic Disease de réir Keith M. Kerr, Krista J. Qualmann, Yoshua Esquenazi, John P. Hagan, Dong Kim
Foilsithe / Cruthaithe 2018Revisão -
12
Subtyping of Undifferentiated Non-small Cell Carcinomas in Bronchial Biopsy Specimens de réir Peh Sun Loo, Stuart C. Thomas, M. Nicolson, Margaret N. Fyfe, Keith M. Kerr
Foilsithe / Cruthaithe 2010Artigo -
13
Pathological assessment of mediastinal lymph nodes in lung cancer: implications for non-invasive mediastinal staging. de réir Keith M. Kerr, D Lamb, C G Wathen, W. S. G. Walker, N J Douglas
Foilsithe / Cruthaithe 1992Artigo -
14
-
15
The Role of DNA Methylation in the Development and Progression of Lung Adenocarcinoma de réir Keith M. Kerr, Janice S. Galler, Jeffrey A. Hagen, Peter W. Laird, Ite A. Laird‐Offringa
Foilsithe / Cruthaithe 2007Revisão -
16
Quantitative Analysis of Tumor in Bronchial Biopsy Specimens de réir Caroline Coghlin, Louise J. Smith, Salmah Bakar, Keith N. Stewart, Graham Devereux, M. Nicolson, Keith M. Kerr
Foilsithe / Cruthaithe 2010Artigo -
17
-
18
Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art? de réir Keith M. Kerr, Ming‐Sound Tsao, Andrew G. Nicholson, Yasushi Yatabe, Ignacio I. Wistuba, Fred R. Hirsch
Foilsithe / Cruthaithe 2015Revisão -
19
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up de réir Pieter E. Postmus, Keith M. Kerr, Matthijs Oudkerk, Suresh Senan, David Waller, Johan Vansteenkiste, Carles Escriu, Solange Peters
Foilsithe / Cruthaithe 2017Artigo -
20
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Internal medicine
Lung cancer
Cancer
Oncology
Pathology
Biology
Lung
Adenocarcinoma
Immunohistochemistry
Genetics
Intensive care medicine
Gene
Biochemistry
Cancer research
Family medicine
Disease
Biomarker
Companion diagnostic
Computer science
Paleontology
Immunotherapy
Medical physics
Radiology
Bioinformatics
Carcinoma
Computational biology
Guideline
Chemotherapy
Clinical trial